A worth reading Analysis of Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX)

73

Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) for the period of 9-Day stands at 19.67% while the stochastic %D for the same period stands at 17.08%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Sell” for Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) while 20-100 Day MACD Oscillator indicates “Sell”.

Bollinger band is a volatility indicator of a certain security, currently Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. Pacira Pharmaceuticals, Inc. is based in New Jersey.

Previous Day Activity Analysis

On the last trading day, Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) opened the session at $34.3 and after going down -1.01% closed at $34.2. The stock lost -0.1 points in the last trade.

Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX)’s stock fluctuated in the range of $33.85 and $34.60 during the previous active session. Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) traded with the volume of 703749 with average volume of 733.31 Million. The stock has MEDIUM volatility on the last trading session.

Currently the Beta for the company remains at 2.08 while ATR (Average True Range) and RSI (Relative Strength Index) are at 1.27 and 36.95 respectively.

Currently the Insider Ownership of the shares of Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) is at 0.8% and the shares outstanding are 40.28 Million.

Important Ratio Analysis

Some important ratios to consider here for Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) are discussed below:

Dividend yield of Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 36.34.

The Price to Sale P/S and Price to Book P/B shows the value of 4.89 and 5.26 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 3.6 and 91.23 correspondingly.

The Quick Ratio of Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) stands at 7.3 while the Current Ratio depicts the value of 7.8.

Return on Assets ROA of Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) is at -13.3% whereas, Return on Equity ROE and Return of Investment ROI of Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) stand at -27.3% and -9.8% respectively.

Stock Performance Analysis

The stock performance of Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) on the basis of 5 day trade show the dip of -2.15% whereas, the monthly performance of the stock shows decrease of -5.79%.

The quarterly performance of the stock remained in red zone with the value of -30.2% while six month performance of the shares of Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) remained bearish with the count of -24%.

The yearly and YTD performance of Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) remained up at 1.63% and 5.88% respectively.